About us

Professor Saleh Abdullah Bawazir graduated with a Bachelor Degree in Pharmacy from King Saud University, Riyadh Saudi Arabia in 1979 and obtained his PhD in clinical pharmacy from the University of Wales Cardiff – U.K. in 1984. Upon his return to Riyadh he was appointed as an assistant professor and the director of the drug and poison information center at the college of pharmacy. Professor Bawazir took the lead as a pioneer in clinical pharmacy practice and contributed enormously to spread the concept of clinical pharmacy among the pharmacists and health care professionals in Saudi Arabia. Furthermore, Professor Bawazir was elected as a chairman for clinical pharmacy department and a member of the college of pharmacy board in 1986. During his chairmanship he worked with colleagues to revise college curriculum towards clinical pharmacy practice and to develop master degree program in clinical pharmacy. Due to his unique vision and expertise in the field of clinical pharmacy he was invited by Iraq and Jorden as a consultant to help in establishing clinical pharmacy programs in their countries. Professor Bawazir is a founding member of the Saudi Pharmaceutical Society (SPS) in 1988 and Saudi Hypertension Management Group in 2001 and Saudi Hypertension Management Society (SHMS) in 2009. In May 2015 professor Bawazir retired from King Saud University and Saudi Food and Drug Authority and he established Bawazir Pharma Consulting Center, Riyadh, Saudi Arabia.

Professor Bawazir research experience include many publications in the fields of pharmacoepidemiology, pharmaceutical policies, bioequivalence and pharmacovigilance. He carried out several national research project as principle investigator and co-investigator such as Evaluation of Drug Delivery System and Drug Utilization in the Kingdom of Saudi Arabia, Future of Pharmaceutical Care in Saudi Arabia and Reforming Health Care Sector in Saudi Arabia.

Prof. of Clinical Pharmacy and CEO,
Bawazir Pharma Consulting Center
Riyadh, Saudi Arabia

At national and international level, he chaired many committees such as registration committee for pharmaceutical products, Pharmacy & Therapeutic Committee, Committee for Reviewing Pharmacy Law and Regulations, Committee for Drugs and Medical Supplies for Hajj, Advisory committee for the National Center for Alternative and Herbal Medicine, Committee for Pricing of Pharmaceuticals, and WHO Expert Committee on Specifications for Pharmaceutical Preparations.

For more than 12 years Prof. Bawazir worked as an advisor to the Executive Office for the Health Ministers of the Arabian Countries on the Gulf. During his work he made several presentations to the Ministers Council and contributed to the development of several successful programs such as group purchasing for pharmaceuticals and medical supplies, bioequivalence and central drug registration for the Gulf Cooperation Council (GCC) countries.

Professor Bawazir worked for eight years as an advisor to the Minister of Health for pharmaceuticals. During his work he chaired the committee that revised and updated the pharmacy law, updated drug registration procedures and established pharmaceuticals pricing guideline. He also represented the Ministry of health in the national committee that negotiate Saudi Arabia accession to the World Trade Organization (WTO) and the committee that establish the Saudi Food and Drug Authority (SFDA).

For the last ten years Professor Bawazir worked as vice president for drug affairs and advisor at the SFDA. During his work he led the drug sector development through a strategic plan and managed to establish a state of the art drug regulatory system that ensure quality, safety and efficacy of the pharmaceutical products and contributed positively to overall public health. Under professor Bawazir supervision the SFDA built many electronic databases and regulatory framework that implement electronic Common Technical Document (eCTD) for drug submissions and established a strong regulatory framework for clinical trials and construct the Saudi Clinical Trial Registry (SCTR) Database. Under professor Bawazir leadership the drug sector at the SFDA is recognized as a leading drug authority in the region and worldwide. Furthermore, Professor Bawazir represented the  GCC for the last eight years in the Global Cooperation Group under the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

Other professional appointments include Consultant, Examiner, Editor, Referee Board Member, Supervisor and chairman of several National Committees. Prof Bawazir is considered an authority in pharmaceutical regulations in Saudi Arabia and the GCC. Prof. Bawazir has more than 200 publications and presentations in scientific meetings and journals and three books.